Cancel
VenoStent
VenoStent Employees
5 people indexed:
-
z7api.ijw33@p0jyhj2p3.zb1 Sign up to see email
-
x10w.whjj0df@l92uluj4q.lx6 Sign up to see email
-
r7bgqr.hud6k88@q3fr2f0h7.6bh Sign up to see email
-
95h5z6qw.52p20qz@994zyhu2p.b0x Sign up to see email
-
Tina McArthur
Vice President of Research and Engineering
y49x.25jq7k7l@f9p79d881.z54 Sign up to see email475z.dp8jxgx0@444bw78dk.024 Sign up to see email
VenoStent Company Information
VenoStent, headquartered in Houston, Texas, operates within the healthcare industry, specifically focusing on medical devices designed to improve vascular surgery outcomes. With a team of 17 employees, the company has developed SelfWrap, a bioabsorbable and flexible vascular wrap that addresses the high failure rates of dialysis access sites within the first year. This innovative product has earned a Breakthrough Device Designation from the FDA and is currently undergoing a 200-subject clinical trial in the United States. VenoStent has successfully completed a $16M Series A financing round and received IDE Approval from the FDA to commence this trial. The company’s efforts are not only technical but also economical, aiming to reduce the annual Medicare costs associated with dialysis access site failures. VenoStent’s expertise spans biomedical engineering, materials engineering, and medical 3D printing, positioning it as a leader in its field. Currently, SelfWrap is in the research and development phase and is not available for sale.
Report inaccurate information
No searches found for this company.
Report inaccurate information
